Cheng Chen

Hepatocyte sortilin 1 knockout and treatment with a sortilin 1 inhibitor reduced plasma cholesterol in Western diet-fed mice

Tiangang Li, Cheng Chen, Jibiao Li, 2019, Journal of Lipid Research.

Inhibition of insulin/PI3K/AKT signaling decreases adipose Sortilin 1 in mice and 3T3-L1 adipocytes.

Tiangang Li, W. Ding, Yuan Li, 2017, Biochimica et biophysica acta. Molecular basis of disease.

Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization

J. Friedman, Tiangang Li, M. N. Hasan, 2022, Proceedings of the National Academy of Sciences.

An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis

Tiangang Li, W. Ding, S. Gunewardena, 2020, Nature Communications.

Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis

Huaiwen Wang, J. Friedman, Tiangang Li, 2021, Cellular and molecular gastroenterology and hepatology.

TFEB regulates sulfur amino acid and coenzyme A metabolism to support hepatic metabolic adaptation and redox homeostasis

Shelly C. Lu, Huaiwen Wang, Yanhong Du, 2022, Nature Communications.

Liver-specific microRNA-185 knockout promotes cholesterol dysregulation in mice

Tiangang Li, Cheng Chen, David J. Matye, 2020, Liver research.

Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice.

Huaiwen Wang, Tiangang Li, W. Ding, 2021, Alcoholism, clinical and experimental research.